Illumina, Inc. Stock 12‑Month Price Target Cut to $264.84, Implies 11% Upside

What happened

Analysts’ average 12-month price target for Illumina fell from $267.47 to $264.84, according to estimates from 19 analysts. The updated target implies approximately 11% potential upside from the Nov. 3 closing price; the consensus rating remains Buy among 24 analysts.

Confirmed

Global impact / market context

The lower average target signals that analysts have trimmed their expectations for Illumina, even while the group rating remains Buy. If expectations shape investor positioning, the change could influence demand for the shares, but it does not establish future company revenue, costs, or results.

Analyst inference

Forecasts span $196 to $365 per share, showing a wide spread in analysts’ views. The 11% implied upside is based on the Nov. 3 closing price, not a guaranteed return; the average target and Buy consensus are estimates, not company guidance.

Confirmed

What to watch

1. Compare future average targets with the current figure of $264.84 to see whether analysts continue lowering or begin raising their expectations for Illumina. Analyst inference
2. Check whether the 24-analyst rating mix changes from 10 Buys, 10 Holds, and 4 Sells, since shifts may signal changing views on the shares. Analyst inference
3. Track company updates on sales, costs, and cash available; stronger or weaker results could help explain whether analyst targets and ratings change. Analyst inference

Evidence

• Original source link unavailable